A number of research firms have changed their ratings and price targets for Core Scientific (NASDAQ: CORZ):
- 9/23/2026 – Core Scientific is now covered by UBS Group AG. They set a “buy” rating and a $24.00 price target on the stock.
- 9/23/2026 – Core Scientific is now covered by UBS Group AG. They set a “buy” rating and a $24.00 price target on the stock.
- 9/21/2026 – Core Scientific is now covered by Rothschild & Co Redburn. They set a “neutral” rating and a $16.00 price target on the stock.
- 9/21/2026 – Core Scientific is now covered by Rothschild & Co Redburn. They set a “neutral” rating and a $16.00 price target on the stock.
- 9/17/2026 – Core Scientific is now covered by Wells Fargo & Company. They set an “overweight” rating and a $28.00 price target on the stock.
- 9/17/2026 – Core Scientific is now covered by Wells Fargo & Company. They set an “overweight” rating and a $28.00 price target on the stock.
Insiders Place Their Bets
In other Core Scientific news, insider Todd DuChene sold 10,000 shares of the business’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $19.97, for a total value of $199,700.00. Following the completion of the sale, the insider directly owned 1,969,101 shares of the company’s stock, valued at $39,322,946.97. The trade was a 0.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Eric Weiss purchased 7,000 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were acquired at an average price of $19.19 per share, with a total value of $134,330.00. Following the completion of the transaction, the director owned 259,262 shares of the company’s stock, valued at approximately $4,975,237.78. This trade represents a 2.77% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last quarter, insiders purchased 19,000 shares of company stock worth $342,290 and sold 90,000 shares worth $1,730,100. 1.70% of the stock is owned by company insiders.
The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.
Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.
Recommended Stories
- Five stocks we like better than Core Scientific
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Core Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.
